186 related articles for article (PubMed ID: 3123496)
1. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts.
Pöllänen J; Hedman K; Nielsen LS; Danø K; Vaheri A
J Cell Biol; 1988 Jan; 106(1):87-95. PubMed ID: 3123496
[TBL] [Abstract][Full Text] [Related]
2. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
Pöllänen J; Saksela O; Salonen EM; Andreasen P; Nielsen L; Danø K; Vaheri A
J Cell Biol; 1987 Apr; 104(4):1085-96. PubMed ID: 3104349
[TBL] [Abstract][Full Text] [Related]
3. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
[TBL] [Abstract][Full Text] [Related]
4. Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin.
Hébert CA; Baker JB
J Cell Biol; 1988 Apr; 106(4):1241-7. PubMed ID: 3129438
[TBL] [Abstract][Full Text] [Related]
5. Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells.
Del Rosso M; Pedersen N; Fibbi G; Pucci M; Dini G; Anichini E; Blasi F
Exp Cell Res; 1992 Dec; 203(2):427-34. PubMed ID: 1333982
[TBL] [Abstract][Full Text] [Related]
6. Immunoelectron microscopic studies of the sites of cell-substratum and cell-cell contacts in cultured fibroblasts.
Chen WT; Singer SJ
J Cell Biol; 1982 Oct; 95(1):205-22. PubMed ID: 6815205
[TBL] [Abstract][Full Text] [Related]
7. Association of fibronectin and vinculin with focal contacts and stress fibers in stationary hamster fibroblasts.
Singer II
J Cell Biol; 1982 Feb; 92(2):398-408. PubMed ID: 6801062
[TBL] [Abstract][Full Text] [Related]
8. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
[TBL] [Abstract][Full Text] [Related]
9. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
11. Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells.
Glass WF; Kreisberg JI; Troyer DA
Am J Physiol; 1993 Mar; 264(3 Pt 2):F532-9. PubMed ID: 8384415
[TBL] [Abstract][Full Text] [Related]
12. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.
Myöhänen HT; Stephens RW; Hedman K; Tapiovaara H; Rønne E; Høyer-Hansen G; Danø K; Vaheri A
J Histochem Cytochem; 1993 Sep; 41(9):1291-301. PubMed ID: 8394852
[TBL] [Abstract][Full Text] [Related]
13. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
Moser TL; Enghild JJ; Pizzo SV; Stack MS
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.
Jensen PH; Christensen EI; Ebbesen P; Gliemann J; Andreasen PA
Cell Regul; 1990 Dec; 1(13):1043-56. PubMed ID: 1966892
[TBL] [Abstract][Full Text] [Related]
16. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
Cajot JF; Schleuning WD; Medcalf RL; Bamat J; Testuz J; Liebermann L; Sordat B
J Cell Biol; 1989 Aug; 109(2):915-25. PubMed ID: 2503527
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
[TBL] [Abstract][Full Text] [Related]
18. Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor.
Casslén B; Nordengren J; Gustavsson B; Nilbert M; Lund LR
J Clin Endocrinol Metab; 1995 Sep; 80(9):2776-84. PubMed ID: 7673423
[TBL] [Abstract][Full Text] [Related]
19. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
[TBL] [Abstract][Full Text] [Related]
20. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.
Anichini E; Zamperini A; Chevanne M; Caldini R; Pucci M; Fibbi G; Del Rosso M
Biochemistry; 1997 Mar; 36(11):3076-83. PubMed ID: 9115983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]